Drugs and Devices
by Jenna Ogilvie | Oct 28, 2019 | Commentary, Perspectives
Introduction One-third of the US population has health literacy levels that are basic or below basic [1]. This statistic, while surprising, is not unique to the United States: limited health literacy impacts access to appropriate health-related services around...
by Jenna Ogilvie | Sep 30, 2019 | Discussion Paper, Perspectives
Introduction Cell-, gene-, and tissue-based advanced therapeutic products, referred to in this paper as “cell and gene therapy” (CGT) products, have the potential to address many unmet medical needs. These products are commonly discovered and developed in...
by Jenna Ogilvie | Sep 9, 2019 | Commentary, Perspectives
Those working on changing the course of the opioid crisis cannot afford to overlook simple solutions that could bring timely, positive results. Changing the policies that impact buprenorphine prescribing could have immediate impacts on access to...
by Jenna Ogilvie | Dec 17, 2018 | Discussion Paper, Perspectives
Introduction Breast cancer is the most common malignancy among women in the United States, with over 260,000 new cases and over 40,000 deaths estimated to occur in 2018 [1]. Although most breast cancers are diagnosed with disease localized to the breast or...
by Jenna Ogilvie | Dec 3, 2018 | Discussion Paper, Perspectives
The central idea of early disease detection and treatment is essentially simple. However, the path to its successful achievement (on the one hand, bringing to treatment those with previously undetected disease, and, on the other, avoiding harm to those...
by Jenna Ogilvie | Oct 22, 2018 | Commentary, Perspectives
Controlling or reducing the risk for cancer was a principal goal of the National Cancer Act, signed by President Nixon in 1971. Long before the human genome was sequenced, and the etiology of many cancers was understood, Americans were determined to find a way...
by Jenna Ogilvie | Oct 1, 2018 | Commentary, Perspectives
Upon arriving in Kenya in 1987, I was a well-trained parasitologist who knew nothing about development, economics, political systems, or structural poverty. Kenya, however, became my classroom. The focus three decades ago was to attack one disease at a time, to...
by Laura DeStefano | Mar 19, 2018 | Discussion Paper, Perspectives
Emerging Opportunities for Digital Health Digital health technologies have emerged in recent years, providing opportunities for engaging with consumers and integrating with the health care system to realize precision medicine, defined as “an evidence-based...
by Jenna Ogilvie | Oct 9, 2017 | Discussion Paper, Perspectives
ABSTRACT | Climbing costs and lengthy time frames of clinical trials are significant bottlenecks in medical product development. Despite the fact that scientific discoveries yield many new possible targets for developing into therapies, the capacity and...
by Jenna Ogilvie | Jul 31, 2017 | Discussion Paper, Perspectives
Antimicrobial Usage and Interventions: A Brief History from 1950 to the Present Antimicrobials for veterinary purposes came on the market in the 1950s, followed shortly by antimicrobial growth promoters (AGPs), because of their growth-enhancing effects to...
